| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.25 | 0.05 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.18 | 0.009 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.008 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |